ValTech Lifesciences
Pre-clinicalValTech Lifesciences is developing the next-gen heart valve designs to improve the hemodynamic performance of existing devices.
Founded
2018
Focus
Small MoleculesDrug DeliveryProteomics
About
ValTech Lifesciences is developing the next-gen heart valve designs to improve the hemodynamic performance of existing devices.
Funding History
2Total raised: $30M
Series A$25MUndisclosedJan 15, 2022
Seed$5MUndisclosedApr 15, 2019
Company Info
TypePrivate
Founded2018
LocationBasel, Switzerland
StagePre-clinical
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile